1. Comparison of the Tyrosine Aminotransferase cDNA and Genomic DNA Sequences of Normal Mink and Mink Affected with Tyrosinemia Type II
- Author
-
Steven R. Leib, David J. Prieur, and Travis C. McGuire
- Subjects
DNA, Complementary ,Molecular Sequence Data ,Animal Diseases ,Tyrosinemia ,Exon ,Tyrosine aminotransferase ,Complementary DNA ,biology.animal ,Genetics ,medicine ,Animals ,Amino Acid Sequence ,Tyrosine ,Mink ,Molecular Biology ,Gene ,In Situ Hybridization, Fluorescence ,Genetics (clinical) ,DNA Primers ,Tyrosine Transaminase ,Tyrosinemia type II ,Base Sequence ,biology ,Tyrosinemias ,Chromosome Mapping ,medicine.disease ,Molecular biology ,Introns ,Biotechnology - Abstract
Type II tyrosinemia, designated Richner-Hanhart syndrome in humans, is a hereditary metabolic disorder with autosomal recessive inheritance characterized by a deficiency of tyrosine aminotransferase activity. Mutations occur in the human tyrosine aminotransferase gene, resulting in high levels of tyrosine and disease. Type II tyrosinemia occurs in mink, and our hypothesis was that it would also be associated with mutation(s) in the tyrosine aminotransferase gene. Therefore, the transcribed cDNA and the genomic tyrosine aminotransferase gene were sequenced from normal and affected mink. The gene extended over 11.9 kb and had 12 exons coding for a predicted 454-amino-acid protein with 93% homology with human tyrosine aminotransferase. FISH analysis mapped the gene to chromosome 8 using the Mandahl and Fredga (1975) nomenclature and chromosome 5 using the Christensen et al. (1996) nomenclature. The hypothesis was rejected because sequence analysis disclosed no mutations in either cDNA or introns that were associated with affected mink. This suggests that an unlinked gene regulatory mutation may be the cause of tyrosinemia in mink.
- Published
- 2005